Common Contracts

2 similar Employment Agreement contracts by Aspira Women's Health Inc.

SECOND AMENDMENT TO Employment Agreement
Employment Agreement • June 27th, 2024 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances

This SECOND AMENDMENT (the “Second Amendment”), dated as of June 5, 2024, (the “Second Amendment Date”) to the Employment Agreement (the “Employment Agreement”), dated May 16, 2023 (“Effective Date”), is made by and among Dr. Torsten Hombeck (“Executive”) and Aspira Women’s Health Inc. and is effective as of June 1, 2024, for itself and on behalf of its wholly owned affiliates (collectively “Aspira” or “Company”).

SECOND AMENDMENT TO Employment Agreement
Employment Agreement • June 7th, 2024 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances

This SECOND AMENDMENT (the “Second Amendment”), dated as of June 5, 2024, (the “Second Amendment Date”) to the Employment Agreement (the “Employment Agreement”), dated May 16, 2023 (“Effective Date”), is made by and among Dr. Torsten Hombeck (“Executive”) and Aspira Women’s Health Inc. and is effective as of June 1, 2024, for itself and on behalf of its wholly owned affiliates (collectively “Aspira” or “Company”).